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Non-coding RNAsPiwi-interacting RNAs (piRNAs) are 26–31 nt small noncoding RNAs that are processed from their longer
precursor transcripts by Piwi proteins. Localization of Piwi and piRNA has been reported mostly in
nucleus and cytoplasm of higher eukaryotes germ-line cells, where it is believed that known piRNA
sequences are located in repeat regions of nuclear genome in germ-line cells. However, localization of
PIWI and piRNA in mammalian somatic cell mitochondria yet remains largely unknown. We identiﬁed
29 piRNA sequence alignments from various regions of the human mitochondrial genome. Twelve out
29 piRNA sequences matched stem-loop fragment sequences of seven distinct tRNAs. We observed their
actual expression in mitochondria subcellular fractions by inspecting mitochondrial-speciﬁc small RNA-
Seq datasets. Of interest, the majority of the 29 piRNAs overlapped with multiple longer transcripts
(expressed sequence tags) that are unique to the human mitochondrial genome. The presence of mature
piRNAs in mitochondria was detected by qRT-PCR of mitochondrial subcellular RNAs. Further validation
showed detection of Piwi by colocalization using anti-Piwil1 and mitochondria organelle-speciﬁc protein
antibodies.
 2014 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-SA license.1. Introduction
Piwi family proteins and their cognate small non-coding RNAs
(Piwi-interacting RNAs, piRNAs), are essential for the differentia-
tion of male primordial germ cells [1,2]. It is believed that they
protect the genome by facilitating transcriptional and post-tran-
scriptional silencing of transposable elements via heterochromati-
zation and endonucleolytic cleavage, respectively [3–5].
The piRNAs are small noncoding RNAs of 26–31 nucleotides in
length, and are generally processed from their longer precursors
that are transcribed from repetitive elements, introns and 30UTRregions [1]. During processing, Piwi family proteins are involved
in cleavage of the longer piRNA precursors [1,2].
Consistent with their association with piRNAs, Piwi family pro-
teins, generally localized in the cytosol and nucleus, are associated
with DNA methylation, transposon repression, and translational
repression, in germ line cells and somatic follicular cells of the Dro-
sophila ovary [5,6]. Piwi family proteins and piRNAs have also been
identiﬁed in higher eukaryotes and the mammalian Piwi ortholog
has been implicated in infertility and cancer [6–9]. However, de-
spite increased recognition of Piwi and piRNAs in the pathogenic
associations, piRNA sequence location and Piwi localization to
mitochondria remains largely unknown [10–12].
In this study, we utilized both computational and experimental
analyses to study the possible presence of Piwi and piRNA tran-
scripts in mitochondria from human normal and cancer cell lines.
Using small RNA-Seq databases, we identiﬁed mitochondrial piR-
NA transcripts which comprise a previously unknown subset of
mitochondrial small non-coding RNAs. Considering piRNAs have
their longer precursors [1,2], we also discovered multiple long
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lapped the piRNA transcripts. Further support for mitochondrial
presence of piRNA and Piwi, was provided by qRT-PCR and Wes-
tern blot in mitochondrial subcellular fractions. To our knowledge,
this is the ﬁrst report on localization of piRNAs and Piwi proteins in
mammalian cancer cell mitochondria.2. Material and methods
2.1. Mapping piRNAs and mitochondrial small RNA-Seq to mtDNA
In order to locate piRNA sequences in mtDNA, we mapped
known piRNA sequences [13] to the human mitochondrial genome
[GenBank: NC_001807], which was downloaded from UCSC Gen-
ome Browser (GB) web site (genome.ucsc.edu). Carmell and col-
leagues experimentally identiﬁed the piRNA sequences [13].
Using those sequences [13] [GenBank: DQ539889 to DQ569912]
from NCBI GenBank, we found 29 piRNAs (Fig. 1) that formed per-
fect matches with the mtDNA genomic sequence by using BLAST
(Table S1). Moreover, 12 out of the 29 identiﬁed piRNAs also per-
fectly matched sequence fragments from seven tRNAs (tRNA-Phe,
-Val, -Leu, -His, -Ser, -Glu, and -Thr).
We used small RNA-Seq datasets (from mitochondrial subcell-
uar fractions) to measure read depths of the 29 piRNA regions in
mitochondria. Based on the multiple datasets, we inspected the
read depths of the piRNAs. The small RNA-Seq dataset of HeLa
and HEK293 cells was downloaded from NCBI Gene Expression
Omnibus (GEO, ncbi.nlm.nih.gov/geo) under the accession number
GSE32185 [10] (see read length distribution in Fig. S1). The small
RNA-Seq dataset of 143B cell line was obtained from NCBI GEO un-
der the accession number GSM763531 [12]. We then ﬁltered the
small RNA-Seq reads by using FASTQ Groomer (galaxyproject.org)
[14], with default options and a minimum Phred quality score of
20. The small RNA-Seq reads of the three cell lines were mapped
to the human mitochondrial genome [GenBank: NC_001807] by
using the default options of the Burrows–Wheeler Alignment tool
(BWA) [15] and SAMtools [16]. Read depths at mitochondrial
DNA (mtDNA) genomic positions were obtained using the default
options of BEDTools [17], and are visualized in Fig. 2A. To deter-
mine the expression of each 50 and 30 tRNA fragment (Fig. 2B and
Table S2), we calculated the average read depth for each fragment.
The expression of the 50 fragment was measured by the average
read depth of the 26 bases in the middle of the tRNA 50 half region.
The expression of the 30 fragment was measured by the average
read depth of the 26 bases in the middle of the tRNA 30 half region.Scale
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Fig. 1. Mitochondrial genomic location of the 29 piRNAs. The panel has two tracks: the 29
throughout mitochondrial genome, including rRNA regions, tRNA regions, and protein-c2.2. Identiﬁcation of uniquely mtDNA-mapped expressed sequence
tags (ESTs) containing the 29 piRNAs
Since expressed sequence tags (ESTs) contain non-coding RNA
fragments and their precursor fragments [18], we reasoned that
the longer ESTs around the piRNAs exist as their precursors (or pre-
cursor-like transcripts). We further focused on uniqueness of the
ESTs in mtDNA (not in nuclear DNA), since the unique alignment
indicates the ESTs are soley transcribed from mtDNA. To assess
whether unique mitochondrial ESTs contained the 29 piRNA se-
quences, we used the GenBank EST (ncbi.nlm.nih.gov/dbEST) align-
ment information table all.est deposited in the UCSC GB [19],
extracting unspliced ESTs uniquely mapped to mtDNA (not nuclear
DNA). The alignment was made by BLAT [19]. That comparison of
the unique ESTs and the piRNAs (using the UCSC GB table browser
tool) resulted in our identiﬁcation of 4494 mitochondria-speciﬁc,
unspliced ESTs overlapping (or partially overlapping) the 29 piRNA
sequences. In addition, tissue- and cell type-speciﬁcities of the piR-
NA-containing ESTs were obtained from table gbCdnaInfo that in-
cludes library description information (e.g., cell- and tissue-type),
as extracted from the UCSC Genome Browser database [19].
2.3. Western blot analysis
Neuroblastoma Neuro2a cells were fractionated by differential
centrifugation, as previously described by Yu et al. [20]. Brieﬂy,
after washing with PBS, cells were resuspended in isotonic homog-
enization buffer (10 mM Tris–HCl (pH 7.4), 250 mM sucrose,
10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM dithiothreitol and
protease inhibitor cocktail). After 100 strokes in a Dounce homog-
enizer, unbroken cells were removed by centrifugation at 30g for
5 min. The nuclei and mitochondrial fractions were prepared from
the resuspended pellets by centrifugation at 80g for 10 min and
6000g for 20 min, respectively. The ﬁnal supernatant was used
as the cytosolic fraction.
For Western blot analysis, protein samples were separated by
SDS–PAGE, transferred to PVDF membranes, and incubated with
primary antibodies against Lamin-B (Abcam), Piwi (Abcam;
ab12337 (Anti-PIWIL1 antibody)), b-actin (Abcam), and Tom40
(Santa Cruz Biotech, a mitochondrial marker) antibodies. Following
incubation with HRP-conjugated secondary antibodies, immunolu-
minescence was determined using ECL Prime kits (GE Healthcare).
Thus, we used Lamin-B, Tom40, and a-tubulin antibodies as nucle-
ar, mitochondrial, and cytosolic markers, respectively, to examine
possible colocalization with Piwi. b-actin was used as a loading
control.hg19
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Fig. 2. Distribution of small RNA reads of mitochondrial subcellular fractions from HeLa, HEK293, and 143B cells. (A) This panel consists of four tracks: mtDNA gene
annotation (including tRNA, rRNA, and protein-coding genes), belowwhich are small RNA-Seq reads from HeLa (top), HEK293 (middle), and143B (bottom) cells. Dashed boxes
in orange indicate 7 tRNAs (of mtDNA) encompassing piRNAs. The regions of the piRNAs in the tRNAs are represented in B. (B) At the bottom row of the table, the tRNA
subsequence encompassing each piRNA is shown in red. In the third row, the three columns for each tRNA indicate the average read depths of HeLa, HEK293, and 143B cells,
respectively. The average depths for the 50 region and the 30 region of each tRNA in the three cell lines are presented as bar graphs: red bars indicate expression levels of each
speciﬁc piRNA-corresponding fragment; gray bars represent the expression of the non-piRNA-corresponding fragments. The percentage represented in bar graph was
obtained from the average read depth of the region divided by summation of the average read depths of both 50 and 30 regions in the tRNA (Table S2). (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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HeLa (HeLa-S3) cell total RNA was isolated from whole cells or
speciﬁc subcellular fractions (i.e., cytosol, mitochondrial, and/or
nuclear) using TRIzol reagent (Invitrogen), according to the manu-
facturer’s protocol. cDNA was prepared using the Quanti-Mir RT
system (System Bioscience, Inc.) according to the manufacturer’s
protocol. The abundance of speciﬁc transcripts was assessed by
quantitative (q)PCR analysis using a SYBR green PCR master mix
(Kapa Biosystems). The piRNA-speciﬁc primer sequences ([Gen-
Bank: DQ590013] (piR-57125), 50-TGGTCGTGGTTGTAGTCCG
TG-30; [GenBank: DQ598641] (piR-36707), 50-GTTAAGATGGCAGA
GCCCGG-30; [GenBank: DQ598675] (piR-36741), 50-GTTTAGAC
GGGCTCACATCAC-30) and universal reverse primer (System Biosci-
ence, Inc.) were used. RT-qPCR analysis was performed with Ap-
plied Biosystems 7300 model. The piRNA expression was
normalized to the small RNA U1 [21].3. Results
3.1. Mapping piRNAs and mitochondrial small RNA-Seq to mtDNA
As recent studies have reported the presence of small RNAs in
the mitochondria, the possibility that a subset of these could be
piRNA species remains. To examine this, we ﬁrst located perfectly
aligned piRNA sequences in mtDNA and subsequently obtained
read depths of the mtDNA-mapped piRNAs by aligning small
RNA-Seq reads.
As a result, we identiﬁed that a total of 29 piRNAs (Table S1)
formed perfect matches with the mtDNA genomic sequence[10,12]. Of those 29 piRNAs, 12 mapped to subsequences of the 7
tRNAs (tRNA-Phe, -Val, -Leu, -His, -Ser, -Glu, and -Thr), 14 mapped
to subsequences of the 12S and 16S rRNAs, and three mapped to
subsequences of the mitochondrial protein-coding genes COX2,
ND4L, and ND5 (Fig. 1).
We subsequently inspected mitochondrial small RNA-Seq data-
sets frommalignant (HeLa, 143B) and normal (HEK293) human cell
lines [10,12], obtained from NCBI GEO (accession number:
GSE32185, GSM763531), to determine the expression (i.e., read
depths) of the piRNAs in mitochondria. Fig. 2A demonstrated the
read depth distributions of mitochondrial small RNA reads from
the three cell lines. The seven tRNA regions (depicted in the orange
box in Fig. 2A) encompassing the 12 piRNA sequences revealed
small RNA reads. Intriguingly, we also observed an asymmetric
tRNA fragment usage from their 50 and 30 regions, as implicated
by differential read mapping (Fig. 2B). We found that HeLa, 143B,
and HEK293 cells favored 50 tRNA fragments over 30 fragments
by factors of 1.4, 1.7, and 2.5, respectively (Table S2). Conversely,
in all three cell lines, 30 fragments of the tRNA-Val and -His were
favored over 50 fragments, while the 30 fragments of tRNA-Phe in
HeLa and HEK293 cells (in contrast to 143B cells) were favored
over 50 fragments (Fig. 2B). Likely asymmetric fragment usage
was further illustrated by HeLa and HEK293 tRNA-Glu and -Thr
preferences for 50 fragments, again in contrast to 143B cells (which
favored 30 fragment matches) (Fig. 2B).
We also found piRNA sequences that matched both the 50 and 30
fragments of tRNA-Ser (Fig. 2B), suggesting dual-end generation of
piRNAs. Out of the seven tRNAs matching the 12 piRNAs, tRNA-Leu
associated with a highly expressed (>98%) piRNA, piR-36707 [Gen-
Bank: DQ598641] in all the three cell lines (HeLa, HEK293, 143B),
while tRNA-His in HEK293 and 143B cells associated with two
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Bank: DQ591357] and [GenBank: DQ579193], respectively) (Fig. 2B
and Table S2). This observation is consistent with cell type-speciﬁc
activities (or subcellular localizations) of distinct tRNA endoribo-
nucleases and/or RNase inhibitors [22,23] involved in RNA process-
ing. Since the tRNA fragments have common or differential usages
in the three cell types, piRNA expression could also be closely cor-
related with the expression of their precursor transcripts.
3.2. ESTs overlapping with piRNA sequences map uniquely to mtDNA
To identify possible mtDNA-derived precursor transcripts, we
inspected the GenBank EST database (ncbi.nlm.nih.gov/dbEST/)
and the alignment table [19] of the UCSC Genome Browser (geno-
me.ucsc.edu). We reasoned that since mitochondrial-unique, long
ESTs could include non-coding RNA fragments and their precursor
fragments [18], these might represent alternative piRNA precursor
fragments (besides nuclear DNA). It is important that the unique
assignment of the longer ESTs to mtDNA (not nuclear DNA) at least
indicates mtDNA-derived transcription of the potential piRNA pre-
cursors. Thus, unspliced EST transcripts uniquely mapping to the
mitochondrial genome might represent potential mtDNA-encoded
precursors of the mitochondrial piRNAs.
As ESTs are generally longer than small RNAs (or tRNAs), we can
identify not only mitochondria-unique ESTs, but also their library
description information (e.g., cell type, tissue type). As a result, uti-
lizing publicly available GenBank EST sequences aligned by the
UCSC GB, we identiﬁed 4494 mitochondria-unique ESTs (Fig. 3A,
visualized by Integrative Genomics Viewer [24]) overlapping
majority of the 29 piRNAs. This result strongly suggests that pro-
cessing of mitochondrial piRNA precursors into their mature piR-
NAs occurs within that speciﬁc organelle. In other words, the
result would imply that some fraction of these 29 piRNAs comes
from biogenesis of piRNAs in the mitochondria, as well as results
from intracellular translocation of nuclear RNA transcripts into
mitochondria.
We further assessed possible tissue speciﬁcity of the mitochon-
drial genome-speciﬁc unspliced ESTs overlapping the 29 piRNAs.
That analysis demonstrated a global tissue distribution of these
ESTs in normal tissues and tumors, including hepatocellular, gas-
tric (GC), kidney, neuroblastoma, cervical, osteosarcoma, prostate,
and endometrial cancers (Table S3). Consequently, this result sup-
ports both global and cancer-associated, mitochondria-speciﬁc
(and not nuclear DNA) transcription of potential piRNA precursors.
We also analyzed the library description information of the
mtDNA-unique unspliced ESTs in various normal and cancer cell
lines, revealing GC, neuroblastoma, and prostate cancer cells to
possess the piRNA-associated unspliced ESTs (Table S4). In partic-
ular, we also identiﬁed nine distinct GC cell lines expressing the
unspliced ESTs (Table S4), in agreement with a previous study
showing upregulated piRNA expression in GC and other cancer
cells [25]. Consequently, our EST analysis suggests that cancer cells
differentially transcribe mitochondrial piRNA precursors. Mini-
mally, our analysis suggests that cell/tissue-speciﬁc transcription
in mitochondria in terms of the precursor-like transcripts associ-
ated with the piRNAs (Tables S3 and S4).
3.3. Subcellular distribution of piRNAs and Piwi proteins
To conﬁrm the assignment of three abundant mature piRNA se-
quences (DQ590013, DQ598641, and DQ598675) to subsequences
of mitochondrial tRNAs-Glu, -Leu, and -Phe, we quantiﬁed their
expression levels by qRT-PCR in HeLa-S3 cells. Those analyses
demonstrated that these three mitochondrial piRNAs exist not only
in mitochondrial subcellular fractions, but also in the cytoplasm
and nucleus (Fig. 3B).As shown in Fig. 3B, those assessments also demonstrated
DQ590013 (piR-57125) and DQ598641 (piR-36707) as predomi-
nantly cytosolic, while DQ598675 (piR-36741) was abundant in
both the mitochondria and nucleus. These ﬁndings suggest that
piRNAs, in general, are distributed unevenly throughout various
subcellular compartments.
While a mitochondrial presence of Piwi proteins has been
shown in murine germ-line cells [11], we are not aware of any re-
ported presence in the mitochondria of mammalian cells, including
cancer cells. Since Piwi family proteins are known as cognate bind-
ing partners of piRNAs, we thus investigated mitochondrial locali-
zation of Piwil1 protein by inspecting its N-terminus for a possible
mitochondrial targeting signal (NP_004755), using the prediction
tool MitoProt II [26] (ihg.gsf.de/ihg/mitoprot.html). That prediction
demonstrated a high probability (79.3%) of mitochondrial localiza-
tion (Fig. S2).
To conﬁrm that computational result (i.e., high probability of
mitochondrial targeting), we performed Western blot analysis.
Since neuroblastoma was one speciﬁc tumor strongly expressing
the mitochondrial piRNA-matched ESTs (Tables S3 and S4), we
fractionated Neuro2a cell lysates by differential centrifugation into
three subcellular (nuclear, mitochondrial, and cytoplasmic) frac-
tions. The organelle speciﬁcity of those differentially obtained frac-
tions was conﬁrmed by immunoblotting with an antibody against
the mitochondria-speciﬁc protein Tom40, as compared to antibod-
ies against Lamin-B and b-actin, which were found in all three
subcellular fractions (including the cytosol and nucleus) [20]. As
depicted in Fig. 3C, Piwil1 was detected in both nuclear and
mitochondrial fractions, thus supporting our earlier computational
prediction of Piwi translocalization to the mitochondrion.4. Discussion
While the majority of studies on piRNAs and Piwi proteins have
focused on transposable repeats in nuclear DNA of germ-line cells,
we here detected numerous piRNAs to align with mitochondria-
speciﬁc small RNA sequencing libraries in cancer cells. Through
computational analysis, piRNAs in mitochondria can be transcribed
from mtDNA itself, but we should not exclude the possibility of
translocation of piRNAs from the nucleus (or cytosol) to mitochon-
dria. Our experimental studies further show co-existence of Piwi
protein and its cognate RNAs (piRNAs) in mitochondria, suggesting
possible ‘‘crosstalk’’ of Piwi–piRNA pathways between the nucleus
and mitochondria.
Based on our ﬁndings, we can speculate a possible function(s) of
Piwi/piRNAs in the mitochondria. Our ﬁndings raise a possibility
that mt piRNAs likely derive from mt tRNAs and rRNAs. These mt
piRNAs need to be inspected in terms of possible association with
stress responses [22,27]. Of interest, in the parasite Leishmania, a
Piwi analog localizes to its single mitochondrion and may play a
role in mitochondria function and resistance to apoptosis [28]. As
mitochondria are well known contributors to oxidative stress
[22,29], one could postulate mt piRNA and Piwi involvement in
mediating cellular behavior related to such stress.
Since cancer cells often beneﬁt from enhanced stress responses
[30], it is possible that mitochondrial Piwi and tRNA-generated
piRNAs could contribute to cellular injury repair mechanisms. In-
deed, we found high expression levels of mt piRNA precursor tran-
scripts in numerous cancer cell types and tumors (Tables S3 and
S4), in agreement with a previous study showing elevated piRNA
levels in gastric cancer cells [25].
In agreement with our current indication of the presence of
neuroblastoma mitochondrial Piwi, it was previously shown that
Piwi knockdown in Drosophila melanogaster suppressed the growth
of malignant brain tumors [31]. Additional support for a
C 
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Fig. 3. Presence of piRNA sequences and Piwi in mitochondria. (A) The 4494 mitochondrial-unique unspliced ESTs overlapping the 29 piRNAs. The ﬁrst track (red horizonal
bar) indicates whole human mtDNA. The second track represents the locations of the 29 piRNAs. The last track shows the locations of all the 4,494 ESTs. (B) Expression of the
three mtDNA-derived piRNAs (normalized to small RNA U1) in the three subcellular fractions (nucleus, cytosol, and mitochondria) in HeLa-S3. The piRNAs are present not
only in the mitochondria but also in the cytoplasm and nucleus, implying complex dynamics of subcellular translocation. (C) Subcellular distribution of Piwi protein in
Neuro2a cells. Piwi was found in mitochondria, nucleus, and cytoplasm (thus conﬁrming mitochondrial localization). Lamin-B, and Tom40 antibodies were used as markers
for nucleus and mitochondria fractions, respectively. b-actin antibody was used for loading control. WCE (whole cell), Nu (nucleus), Mito (mitochondria), and Cyto
(cytoplasm). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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studies showing elevated Piwi expression in several human cancer
types, in positive association with epigenetic anomalies, stem cell-
like characteristics, poor prognosis, high grade, and a high prolifer-
ative index [6,8,9].In summary, in extension of previous studies in germline cells,
we report a ﬁnding of expression of piRNAs and Piwi proteins in
cancer cell mitochondria that are closely aligned with numerous
functions of that organelle in physiological homeostasis, bioener-
getics, and a growing number of pathologies.
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